Insider trades

Kenneth A. Lock, Chief Officer of Arcutis Biotherapeutics ARQT, has filed 0 purchases and 4 sales on the open market. The latest trade was on 23/03/06.

Kenneth A. Lock

Chief Commercial Officer
First filing
23/03/02
Trades
6 trades
Buys / sales
0 / 4
12-month net buying
No record
Last trade
23/03/06

Trading activity

Transactions

Trade type
Open-market sale23/03/0623/03/08831 sh$15.26$12,681.06−1.3%
ARQT
Open-market sale23/02/28–23/03/0223/03/022,368 sh3 trades$15.96avg.$37,801.96−5.2%